New eye scan could spot glaucoma risk early
NCT ID NCT06993597
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 37 times
Summary
This pilot study is testing whether a non-contact imaging technique called Brillouin microscopy can measure corneal stiffness in people with glaucoma. Researchers will compare measurements between patients with high-tension glaucoma, normal-tension glaucoma, and healthy controls. They will also track changes after starting standard glaucoma eye drops. The goal is to see if these measurements can serve as biomarkers for glaucoma risk and progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Maryland School of Medicine
RECRUITINGBaltimore, Maryland, 21201-1757, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Brillouin microscopy (non-contact imaging device)
What this could lead to
If successful, this could lead to a new way to detect glaucoma risk and track progression using a simple, non-invasive eye scan.
What could go wrong
This is a small pilot study with only 60 participants, so results may not apply to everyone. The technique is still experimental and not yet proven to predict glaucoma outcomes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.